$enlv should go higher. Identified best population for ph2b, no safety issues and ph3 endpoints are stat significant. Very cheap currently and huge market.
If we want to thoughtfully reduce NIH indirect costs, we need to reduce the federal regulatory burden that causes universities to hire so many administrators to remain compliant.
Problem for western discovery work is 1) losing expertise - many people good at small molecule chem work or protein engineering work - are not ethnically Western - sorry to say - .. why stay at a Pfizer or Mrk and be a grunt for years vs going back "home" as many did in past…
$GOSS - everything you need to know on $GOSS if anyone interested or looking there - Gossamer Bio : “The Revenant of Biotech” alumnicapital.com/gossamer
For my British and European friends who are "shocked" and "surprised", here are 10 reasons you didn't see this coming.
Read this short post and then read the replies from our American friends who will confirm what I'm saying.
1. Americans love their country and want it to be…
532 Followers 45 Following🎤🔥 Rapper of the market & financial educator 🌍
📈 Breaking down Bitcoin, blockchain & market psychology… on funky beats 🎶💃🕺
⚡ Turning rhythm into crypto k
188 Followers 991 FollowingNeuroscientist. Loves everything biotech. Life long learner. Faith and grit will get you ‘there’. Mother of Heidi and Deanna.
721 Followers 139 FollowingWhy do people put "not investment advice" in their bios? Is there actually legal precedent, or do they just do copy others?
Not investment advice.
2K Followers 142 FollowingWe write a newsletter focused on micro/small-cap healthcare cos. Comments are not investment advice. Sometimes we get paid. Disclosures at https://t.co/k7TK1zioAS
3K Followers 426 FollowingMicro and small cap biotech (and some tech). Focus in neurology. Interested in novel MoAs, large and underserved indications, and special situations. Not FA.
3K Followers 93 FollowingCurrently a Factory/Process Automation Consultant in WNY. Long time ChemE having a career spanning eng/maint and sales roles. Please do your own due diligence.
650 Followers 83 FollowingA financial services professional shining a light on the craziness and having fun while doing it. Not investment or medical advice.
3K Followers 680 FollowingBiotech Portfolio Manager, Options Strategist, Indie Films & Philosophy ~You cannot have truth in a way you catch it, but that it catches you ~ Kierkegaard